Robert G. Conway serves as Executive at AGILE THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Robert G. Conway has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 26, 2024 involved selling 10,125 shares valued at $15.4K.
Robert G. Conway currently holds 3,404 shares of AGILE THERAPEUTICS INC (AGRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert G. Conway has been a net neutral trader of AGRX stock. They have purchased $0 and sold $0 worth of shares.
Robert G. Conway's most recent insider trade was on Aug 26, 2024, when they sold 10,125 shares at $1.52 per share.
Get notified when new Form 4 filings are submitted
| 3,404 |
| $1.52 |
| Discretionary |
| Jun 28, 2023 | AGRX | $0 | Award | 13,500 | $N/A | Discretionary |
| Jan 27, 2021 | AGRX | $0 | Award | 35,461 | $N/A | Discretionary |
| Nov 19, 2020 | AGRX | $7.3K | Option Exercise | 4,149 | $1.76 | Discretionary |
| Jan 22, 2020 | AGRX | $0 | Award | 6,272 | $N/A | Discretionary |
| Jan 24, 2019 | AGRX | $2.1K | Payment | 2,350 | $0.89 | Discretionary |
| Jan 24, 2019 | AGRX | $0 | Option Exercise | 8,625 | $N/A | Discretionary |